Differential effects of homocysteine on porcine endothelial and vascular smooth muscle cells

Journal of Cardiovascular Pharmacology

Volumn 39, Issue 5, 2002, Pages 643-651

  Lee, Hae Young ^a   Chae, In Ho ^a   Kim, Hyo Soo ^a   Park, Young Bae ^a   Choi, Yun Shik ^a   Lee, Young Woo ^a   Park, Sun Jung ^a   Cha, Young Joo ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Endothelial cell; Homocysteine; Platelet derived growth factor; Prostacyclin; Vascular smooth muscle cell

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; HOMOCYSTEINE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROSTACYCLIN; TETRAZOLIUM; THYMIDINE;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PRIORITY JOURNAL; SWINE; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; HOMOCYSTEINE; MUSCLE, SMOOTH, VASCULAR; PLATELET-DERIVED GROWTH FACTOR; SWINE;

EID: 0036234234     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200205000-00004     Document Type: Article

References (31)

1. Modeling of risk factors for ischemic stroke: The Willis lecture
2. Homocysteine and vascular disease
3. Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis
4. Homocysteine and atherothrombosis
5. Homocysteine species as components of human redox thiol status
6. Clinical implications of plasma homocysteine measurement in cardiovascular disease
7. Putative mechanisms for vascular damage by homocysteine
8. Hyperhomocysteinemia: An independent risk factor for vascular disease
9. Plasma homocysteine as a risk factor for vascular disease: The European Concerted Action Project
10. Endothelial cell dysfunction in homocystinuria
11. Hyperhomocysteinemia as a risk factor for occlusive vascular disease
12. Homocysteine mediated endothelial cell toxicity and its amelioration
13. Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons
14. Vascular dysfunction in monkeys with diet-induced hyperhomocysteinemia
15. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells
16. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
17. The effect of homocysteine on DNA synthesis in cultured human vascular smooth muscle
18. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II
19. The pathogenesis of atherosclerosis: An update
20. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
21. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor
22. Homocysteine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase
23. Stimulation of endothelial nitric oxide production by homocysteine
24. Effects of homocysteine and related compounds on prostacyclin production by cultured human vascular endothelial cells
25. Peroxide mediated effects of homocysteine on arterial prostacyclin synthesis
26. Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism
27. The biology of platelet derived growth factor
28. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo
29. S-adenosylhomocysteine toxicity in normal and adenosine kinase-deficient lymphoblasts of human origin
30. Homocysteine and hypomethylation